Format

Send to

Choose Destination
Int J Oncol. 2016 Aug;49(2):700-8. doi: 10.3892/ijo.2016.3547. Epub 2016 May 31.

Repression of Smad4 by miR‑205 moderates TGF-β-induced epithelial-mesenchymal transition in A549 cell lines.

Author information

1
Department of Respiratory Medicine, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China.
2
Department of Cardiothoracic Surgery, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China.
3
Suzhou Key Laboratory for Molecular Cancer Genetics, Suzhou, P.R. China.
4
Department of Oncology, The First Affiliated Hospital of Soochow University, Suzhou, P.R. China.

Abstract

The TGF-β/Smad signaling pathway plays important roles in cancer cell proliferation, apoptosis, differentiation, angiogenesis and epithelial-mesenchymal transition (EMT), which is the key event in the early stages of cancer metastasis and enhances the capability of cell migration and invasion. Smad4 acts as the only Co-Smad of TGF/Smad signaling pathway and plays the key role in TGF-β-mediated EMT. Nevertheless, the mRNA regulation mechanisms of Smad4 in human non-small cell lung cancer (NSCLC) remains largely unclear. Computational algorithms predicted that the 3'-UTR of Smad4 is a target of miR‑205. Here, we validated that miR‑205 could directly bind to 3'-UTR of Smad4 by luciferase assays. Moreover, we investigated the functional roles of miR‑205 and its molecular link to Smad4 in lung cancer cells. In this study, we confirmed that overexpression of miR‑205 suppressed the expression of Smad4, in turn, weakened the TGF-β/Smad signaling pathway and inhibited TGF-β/Smad4-induced EMT, invasion and migration ultimately. Furthermore, this study shows that miR‑205 can serve as a promising therapeutic target of highly aggressive NSCLC.

PMID:
27279345
DOI:
10.3892/ijo.2016.3547
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Spandidos Publications
Loading ...
Support Center